HIV Sex-Risk Behaviors among In- versus Out-of-Treatment Heroin-Addicted Adults

REFERENCES

• Gowing L, Farrell M, Bornemann R, Sullivan LE, Ali RH. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev 2011; 10(8):CD004145.
   Google Scholar
• Highfield DA, Schwartz RP, Jaffe JH, O‘Grady KE. Intravenous and intranasal heroin-dependent treatment-seekers: Characteristics and treatment outcome. Addiction 2007; 102(11):1816–1823.
   PubMed Web of Science ®Google Scholar
• Camacho LM, Bartholomew NG, Joe GW, Cloud MA, Simpson DD. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug Alcohol Depend 1996; 41(1):1–7.
   PubMed Web of Science ®Google Scholar
• Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst Use Misuse 1999; 34(8):1137–1165.
   PubMed Web of Science ®Google Scholar
• Gossop M, Marsden J, Stewart D, Rolfe A. Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend 2000; 60(3):275–286.
   PubMed Web of Science ®Google Scholar
• Crowley TJ, Simpson R. Methadone dose and human sexual behavior. Int J Addict 1978; 13(2):285–295.
   PubMed Web of Science ®Google Scholar
• Lott DC, Strain EC, Brooner RK, Bigelow GE, Johnson RE. HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate [corrected] buprenorphine, and methadone. J Subst Abuse Treat 2006; 31(2):187–194.
   PubMed Web of Science ®Google Scholar
• Peterson JA, Reisinger HS, Schwartz RP, Mitchell SG, Kelly SM, Brown BS, Agar MH. Targeted sampling in drug abuse research: A review and case study. Field Methods 2008; 20(2):155–170.
   Web of Science ®Google Scholar
• Simpson DD, Knight K, Ray S. Psychosocial correlates of AIDS-risk drug use and sexual behaviors. AIDS Educ Prev 1993; 5(2):121–130.
   PubMed Web of Science ®Google Scholar
• Metzger DS. The Risk Assessment Battery (RAB): Validity and Reliability. In Sixth Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS, Alexandria, VA, 1993.
   Google Scholar
• Boatler JF, Knight K, Simpson DD. Assessment of an AIDS intervention program during drug abuse treatment. J Subst Abuse Treat 1994; 11(4):367–372.
   PubMed Web of Science ®Google Scholar
• Camacho LM, Brown BS, Simpson DD. Psychological dysfunction and HIV/AIDS risk behavior. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11(2):198–202.
   PubMedGoogle Scholar
• King VL, Kidorf MS, Stoller KB, Brooner RK. Influence of psychiatric comorbidity on HIV risk behaviors: Changes during drug abuse treatment. J Addict Dis 2000; 19(4):65–83.
   PubMed Web of Science ®Google Scholar
• Joe GW, Simpson DD. HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend 1995; 37(1):23–28.
   PubMed Web of Science ®Google Scholar
• Wilson ME, Schwartz RP, O‘Grady KE, Jaffe JH. Impact of interim methadone maintenance on HIV risk behaviors. J Urban Health 2010; 87(4):586–591.
   PubMed Web of Science ®Google Scholar
• Grella CE, Anglin D, Annon JJ. HIV risk behaviors among women in methadone maintenance treatment. Subst Use Misuse 1996; 31(3):277–301.
   PubMed Web of Science ®Google Scholar
• Metzger DS, Woody GE, McLellan AT, O’Brien CP, Druley P, Navaline H, DePhillips D, Stolley P, Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993; 6(9):1049–1056.
   PubMed Web of Science ®Google Scholar
• Schroeder JR, Epstein DH, Umbricht A, Preston KL. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addict Behav 2006; 31(5):868–879.
   PubMed Web of Science ®Google Scholar
• Brown LS, Jr, Kritz SA, Goldsmith RJ, Bini EJ, Rotrosen J, Baker S, Robinson J, McAuliffe P. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat 2006; 30(4):315–321.
   PubMed Web of Science ®Google Scholar
• Tross S, Campbell A, Cohen L, Calsyn D, Pavlicova M, Miele G, Hu M, Haynes L, Nugent N, Gan W, Hatch-Maillette M, Mandler R, McLaughlin P, El-Bassel N, Crits-Christoph P, Nunes E. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: Results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr Hum Retrovirol 2008; 48(5):581–589.
   Google Scholar
• Calsyn DA, Hatch-Maillette M, Tross S, Doyle SR, Crits-Christoph P, Song YS, Harrer JM, Lalos G, Berns SB. Motivational and skills training HIV/sexually transmitting infection sexual risk reduction groups for men. J Subst Abuse Treat 2009; 37(2):138–150.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Effectiveness of Drug Dependence Treatment in Preventing HIV among Injecting Drug Users. Geneva: WHO, 2004.
   Google Scholar
• Sethi AK, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr 2004; 35(5):503–510.
   PubMed Web of Science ®Google Scholar
• Goldstein MF, Friedman SR, Neaigus A, Jose B, Ildefonso G, Curtis R. Self-reports of HIV risk behavior by injecting drug users: Are they reliable? Addiction 1995; 90(8):1097–1104.
   PubMed Web of Science ®Google Scholar